Arkolith/Insider Trading/ELDN/Form 4

Gros David-Alexandre C

Chief Executive Officer, DirectorEledon Pharmaceuticals, Inc. (ELDN) · full profile →Form 4 · filed Jun 10, 2021
Net Buying
Open-Market Buys
$24K
Open-Market Sells
$0
Net Open-Market Flow
$24K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2021Buy(P)3K$8.01$24K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-022998) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML